128 related articles for article (PubMed ID: 1234553)
1. Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4.
Calderini G; Morselli PL; Garattini S
Eur J Pharmacol; 1975 Dec; 34(2):345-50. PubMed ID: 1234553
[TBL] [Abstract][Full Text] [Related]
2. Short and long-term effects of reserpine on the concentration of 1-(4-hydroxy-3-methoxyphenyl)-ethane-1,2-diol (MOPEG-SO4) in the brain of the rat.
Bareggi SR; Genovese E; Markey K
Br J Pharmacol; 1979 Apr; 65(4):573-8. PubMed ID: 435682
[TBL] [Abstract][Full Text] [Related]
3. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
Dolphin A; Jenner P; Marsden CD
J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
[No Abstract] [Full Text] [Related]
4. Effects of single and multiple doses of desipramine (DMI) on endogenous levels of 3-methoxy-4-hydroxyphenylglycol-sulfate (MOPEG-SO4) in rat brain.
Bareggi SR; Markey K; Genovese E
Eur J Pharmacol; 1978 Aug; 50(4):301-6. PubMed ID: 699958
[TBL] [Abstract][Full Text] [Related]
5. Effects of amphetamine, electrical stimulation and stress on endogenous MOPEG-SO4 levels in rat brain.
Bareggi SR; Markey K; Paoletti R
Pharmacol Res Commun; 1978 Jan; 10(1):65-73. PubMed ID: 643891
[No Abstract] [Full Text] [Related]
6. Analgesia and increases in limbic and cortical MOPEG-SO4 produced by periaqueductal gray injections of morphine.
Reigle TG; Wilhoit CS; Moore MJ
J Pharm Pharmacol; 1982 Aug; 34(8):496-500. PubMed ID: 6126559
[TBL] [Abstract][Full Text] [Related]
7. The effect of trauma on the activity of central noradrenergic neurones.
Stoner HB; Hunt A
Brain Res; 1976 Aug; 112(2):337-46. PubMed ID: 953712
[TBL] [Abstract][Full Text] [Related]
8. [Physiological role and clinical significance of 3-methoxy-4-hydroxyethyleneglycol, a noradrenaline metabolite (review of the literature)].
Bol'shakova TD; Shenderovich MIa
Vopr Med Khim; 1987; 33(6):3-11. PubMed ID: 3328414
[TBL] [Abstract][Full Text] [Related]
9. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
[TBL] [Abstract][Full Text] [Related]
10. The effects of several narcotic analgesics on brain levels of 3-methoxy-4-hydroxyphenylethylene glycol sulfate in the rat.
LoPachin RM; Reigle TG
J Pharmacol Exp Ther; 1978 Oct; 207(1):151-8. PubMed ID: 29961
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the neurochemical effects of fenfluramine by previous treatment with d-amphetamine.
Hunsinger RN; Wilson MC
Pharmacol Biochem Behav; 1985 Jan; 22(1):127-34. PubMed ID: 3975238
[TBL] [Abstract][Full Text] [Related]
12. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal.
Borg S; Czarnecka A; Kvande H; Mossberg D; Sedvall G
Alcohol Clin Exp Res; 1983; 7(4):411-5. PubMed ID: 6362467
[TBL] [Abstract][Full Text] [Related]
13. Effects of the d- and l-isomers of amphetamine on the levels of 3-methoxy-4-hydroxyphenylglycol sulfate in whole rat brain and rat brain regions.
Roffman M; Cassens G; Schildkraut JJ
Biochem Pharmacol; 1978; 27(13):1774-7. PubMed ID: 708459
[No Abstract] [Full Text] [Related]
14. Differential changes in noradrenaline turnover in specific regions of rat brain produced by controllable and uncontrollable shocks.
Tsuda A; Tanaka M
Behav Neurosci; 1985 Oct; 99(5):802-17. PubMed ID: 3843302
[TBL] [Abstract][Full Text] [Related]
15. Amphetamine withdrawal: effects on brain levels of MHPG-SO4 in the rat.
Cassens G; Kuruc A; Orsulak PJ; Schildkraut JJ
Commun Psychopharmacol; 1979; 3(4):217-23. PubMed ID: 575083
[No Abstract] [Full Text] [Related]
16. The effect of propranolol on blood pressure and central MOPEG concentration in the conscious spontaneously hypertensive rat.
Keeton TK; Hall JS
Eur J Pharmacol; 1986 Jun; 125(2):293-6. PubMed ID: 3743639
[TBL] [Abstract][Full Text] [Related]
17. Differential actions of d- and 1-amphetamine on the metabolism of 3H-norepinephrine in rat brain.
Peterson DW; Sparber SB
Pharmacol Biochem Behav; 1976 May; 4(5):545-9. PubMed ID: 951433
[TBL] [Abstract][Full Text] [Related]
18. Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings.
Donnelly M; Rapoport JL; Potter WZ; Oliver J; Keysor CS; Murphy DL
Arch Gen Psychiatry; 1989 Mar; 46(3):205-12. PubMed ID: 2645848
[TBL] [Abstract][Full Text] [Related]
19. Tolerance and cross-tolerance to the effects of amphetamine, methamphetamine and fenfluramine on milk consumption in the rat.
Kandel D; Doyle D; Fischman MW
Pharmacol Biochem Behav; 1975; 3(4):705-7. PubMed ID: 1187733
[TBL] [Abstract][Full Text] [Related]
20. The effect of depletion of brain dopamine by 6-hydroxydopamine on tolerance to the anorexic effect of d-amphetamine and fenfluramine in rats.
Heffner TG; Seiden LS
J Pharmacol Exp Ther; 1979 Jan; 208(1):134-43. PubMed ID: 759608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
